01—History
Shares Outstanding History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- 117.8M
02—Ledger
Shares Outstanding, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | 117.8M | −4.3% | 10-K | |
| FY2024 | 123.1M | −2.9% | 10-K | |
| FY2023 | 126.8M | −6.2% | 10-K | |
| FY2022 | 135.2M | −1.7% | 10-K | |
| FY2021 | 137.5M | +1.8% | 10-K | |
| FY2020 | 135.0M | −1.2% | 10-K | |
| FY2019 | 136.7M | −5.5% | 10-K | |
| FY2018 | 144.7M | +1.4% | 10-K | |
| FY2017 | 142.8M | +10.3% | 10-K | |
| FY2016 | 129.5M | +1.1% | 10-K | |
| FY2015 | 128.2M | +1.9% | 10-K | |
| FY2014 | 125.7M | +9.8% | 10-K | |
| FY2013 | 114.5M | +1.6% | 10-K | |
| FY2012 | 112.7M | +8.4% | 10-K | |
| FY2011 | 104.0M | +3.4% | 10-K | |
| FY2010 | 100.6M | — | 10-K |
03—Questions
What is shares outstanding?
Shares outstanding is the total number of common shares currently held by all shareholders, including restricted shares.
What is Halozyme Therapeutics's current shares outstanding?
Halozyme Therapeutics (HALO) annual shares outstanding for 2025 was 117.8M, a 4.35% decline from 2024. Halozyme Therapeutics shares outstanding for the quarter ending September 30, 2026 was 113.9M.
What was Halozyme Therapeutics's shares outstanding in 2024?
Halozyme Therapeutics annual shares outstanding for 2024 was 123.1M, a 2.87% decline from 2023.
What was Halozyme Therapeutics's shares outstanding in 2023?
Halozyme Therapeutics annual shares outstanding for 2023 was 126.8M, a 6.20% decline from 2022.
What is Halozyme Therapeutics's 5-year shares outstanding CAGR?
Halozyme Therapeutics shares outstanding grew at a compound annual growth rate (CAGR) of 2.70% from FY2020 to FY2025, going from 135.0M to 117.8M over 5 years.
- Company
- Halozyme Therapeutics
- Ticker
- HALO
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)